Artal Group S.A. - Q3 2013 holdings

Add to watchlist

$3.07 Billion is the total value of Artal Group S.A.'s 81 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 100.0% .

All

			Value		Shares		↓ Weighting
	Exit	MICROVISION INC DEL*w exp 07/23/201	$0	–	-360,515	-100.0%	0.00%	–
VVUS	Exit	VIVUS INCcall	$0	–	-200,000	-100.0%	-0.08%	–
FSLR	Exit	FIRST SOLAR INC	$0	–	-100,000	-100.0%	-0.14%	–
ARCO	Exit	ARCOS DORADOS HOLDINGS INCcall	$0	–	-400,000	-100.0%	-0.15%	–
FB	Exit	FACEBOOK INCcall	$0	–	-200,000	-100.0%	-0.16%	–
ITUB	Exit	ITAU UNIBANCO HLDG SAspon adr rep pfd	$0	–	-400,000	-100.0%	-0.16%	–
JPM	Exit	JPMORGAN CHASE & CO	$0	–	-100,000	-100.0%	-0.17%	–
SLB	Exit	SCHLUMBERGER LTD	$0	–	-75,000	-100.0%	-0.17%	–
KORS	Exit	MICHAEL KORS HLDGS LTDcall	$0	–	-100,000	-100.0%	-0.20%	–
FB	Exit	FACEBOOK INCcl a	$0	–	-250,000	-100.0%	-0.20%	–
ROC	Exit	ROCKWOOD HLDGS INCcall	$0	–	-100,000	-100.0%	-0.20%	–
MET	Exit	METLIFE INCcall	$0	–	-150,000	-100.0%	-0.22%	–
VLO	Exit	VALERO ENERGY CORP NEWcall	$0	–	-200,000	-100.0%	-0.22%	–
ITUB	Exit	ITAU UNIBANCO HLDG SAcall	$0	–	-550,000	-100.0%	-0.22%	–
EEM	Exit	ISHARES TRcall	$0	–	-200,000	-100.0%	-0.24%	–
ARCO	Exit	ARCOS DORADOS HOLDINGS INC	$0	–	-800,000	-100.0%	-0.29%	–
Q	Exit	QUINTILES TRANSNATIO HLDGS I	$0	–	-225,000	-100.0%	-0.30%	–
EWW	Exit	ISHARES INCmsci mexico cap	$0	–	-150,000	-100.0%	-0.31%	–
VRX	Exit	VALEANT PHARMACEUTICALS INTL	$0	–	-125,000	-100.0%	-0.34%	–
BRFS	Exit	BRF S Asponsored adr	$0	–	-500,000	-100.0%	-0.34%	–
EMR	Exit	EMERSON ELEC COcall	$0	–	-200,000	-100.0%	-0.34%	–
FRX	Exit	FOREST LABS INCcall	$0	–	-300,000	-100.0%	-0.39%	–
COF	Exit	CAPITAL ONE FINL CORPcall	$0	–	-200,000	-100.0%	-0.40%	–
OCN	Exit	OCWEN FINL CORP	$0	–	-350,000	-100.0%	-0.45%	–
MET	Exit	METLIFE INC	$0	–	-400,000	-100.0%	-0.58%	–
AAPL	Exit	APPLE INC	$0	–	-50,000	-100.0%	-0.62%	–
ONXX	Exit	ONYX PHARMACEUTICALS INC	$0	–	-300,000	-100.0%	-0.82%	–
ONXX	Exit	ONYX PHARMACEUTICALS INCcall	$0	–	-300,000	-100.0%	-0.82%	–
EWJ	Exit	ISHARES INCcall	$0	–	-2,500,000	-100.0%	-0.88%	–
EWZ	Exit	ISHARES INCcall	$0	–	-2,000,000	-100.0%	-2.76%	–

Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR filed 2013-11-14

Signatures

The EDGAR filing(s) were signed by:

Anne Goffard — Authorized Person

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
AGENUS INC	42	Q3 2023	1.9%
IRONWOOD PHARMACEUTICALS INC	42	Q3 2023	0.3%
ALNYLAM PHARMACEUTICALS INC	37	Q3 2023	5.1%
LEXICON PHARMACEUTICALS INC	34	Q3 2023	20.6%
AMICUS THERAPEUTICS INC	30	Q3 2023	2.7%
BEIGENE LTD	28	Q3 2023	7.4%
BK OF AMERICA CORP	28	Q1 2021	4.3%
SAGE THERAPEUTICS INC	28	Q2 2023	1.9%
AGIOS PHARMACEUTICALS INC	28	Q2 2020	1.1%
NEKTAR THERAPEUTICS	27	Q2 2020	1.3%

View Artal Group S.A.'s complete holdings history.

Latest significant ownerships (13-D/G)

Artal Group S.A. Q3 2013 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
WEIGHT WATCHERS INTERNATIONAL INC	February 13, 2015	29,443,300	51.9%

View Artal Group S.A.'s complete significant-ownership history.

Latest filings

Type	Filed
13F-HR/A	2024-05-17
4	2024-05-14
13F-HR	2024-05-13
4	2024-03-25
4	2024-03-13
4	2024-02-29
13F-HR	2024-02-09
13F-HR	2023-11-13
4	2023-10-16
13F-HR	2023-08-11

View Artal Group S.A.'s complete filings history.

All filings

View complete filings history.

Compare quarters

Export Artal Group S.A.'s holdings